NIH-funded research R21 grant

Investigating racial differences in colorectal cancer through DNA methylation

Official title: Racial Disparities and Colorectal DNA Methylation- Driven Gene Expression

Funded at University of Virginia · NIH-10726172 · Data updated 2026-11-12

This study is looking at how differences in DNA between African Americans and European Americans might explain why African Americans are more likely to develop colorectal cancer, especially on the right side and at a younger age, so we can better understand and address these health disparities.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startSeptember 15, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$415,257
NIH project number1R21CA283132-01
Project IDNIH-10726172 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include African American and European American individuals diagnosed with colorectal cancer or at high risk for the disease.

Less likely to help

Patients who do not have colorectal cancer or are not at risk for the disease may not benefit from this research.

What this research studies

This research explores how racial disparities affect the development of colorectal cancer (CRC), particularly focusing on the differences in DNA methylation patterns between African Americans and European Americans. By analyzing colorectal biopsies and patient-derived organoids, the study aims to uncover how these epigenetic changes influence gene expression and tumor development. The research seeks to understand why African Americans are more likely to develop right-sided CRC at a younger age compared to their European American counterparts. Through this investigation, the researchers hope to identify the biological mechanisms that contribute to these disparities.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and targeted interventions for colorectal cancer in racially diverse populations.

How similar studies have gone: Previous research has indicated that epigenetic factors play a significant role in cancer disparities, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Li, Li — University of Virginia
  • Study coordinator: Li, Li

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.